31724513|t|Tau PET Distributional Pattern in AD Patients with Visuospatial Dysfunction.
31724513|a|BACKGROUND: Visuospatial dysfunction is one predominant symptom in many atypical Alzheimer's disease (AD) patients, however, until now its neural correlates still remain unclear. For the accumulation of intracellular hyperphosphorylated tau proteins is a major pathogenic factor in neurodegeneration of AD, the distributional pattern of tau could highlight the affected brain regions associated with specific cognitive deficits. OBJECTIVE: We investigated the brain regions particularly affected by tau accumulation in patients with visuospatial dysfunction to explore its neural correlates. METHODS: Using 18F-AV-1451 tau positron emission tomography (PET), voxel-wise two-sample t-tests were performed between AD patients with obvious visuospatial dysfunction (VS-AD) and cognitively normal subjects, AD patients with little-to-no visuospatial dysfunction (non VS-AD) and cognitively normal subjects, respectively. RESULTS: Results showed increased tau accumulations mainly located in occipitoparietal cortex, posterior cingulate cortex, precuneus, inferior and medial temporal cortex in VS-AD patients, while increased tau accumulations mainly occurred in the inferior and medial temporal cortex in non VS-AD patients. CONCLUSION: These findings suggested that occipitoparietal cortex, posterior cingulate cortex and precuneus, which were particularly affected by increased tau accumulation in VS-AD patients, may associate with visuospatial dysfunction of AD.
31724513	0	3	Tau	Gene	4137
31724513	34	36	AD	Disease	MESH:D000544
31724513	37	45	Patients	Species	9606
31724513	51	75	Visuospatial Dysfunction	Disease	MESH:D000377
31724513	89	113	Visuospatial dysfunction	Disease	MESH:D000377
31724513	158	177	Alzheimer's disease	Disease	MESH:D000544
31724513	179	181	AD	Disease	MESH:D000544
31724513	183	191	patients	Species	9606
31724513	314	317	tau	Gene	4137
31724513	359	376	neurodegeneration	Disease	MESH:D019636
31724513	380	382	AD	Disease	MESH:D000544
31724513	414	417	tau	Gene	4137
31724513	486	504	cognitive deficits	Disease	MESH:D003072
31724513	576	579	tau	Gene	4137
31724513	596	604	patients	Species	9606
31724513	610	634	visuospatial dysfunction	Disease	MESH:D000377
31724513	696	699	tau	Gene	4137
31724513	789	791	AD	Disease	MESH:D000544
31724513	792	800	patients	Species	9606
31724513	814	838	visuospatial dysfunction	Disease	MESH:D000377
31724513	840	845	VS-AD	Disease	MESH:D000377
31724513	880	882	AD	Disease	MESH:D000544
31724513	883	891	patients	Species	9606
31724513	910	934	visuospatial dysfunction	Disease	MESH:D000377
31724513	940	945	VS-AD	Disease	MESH:D000377
31724513	1028	1031	tau	Gene	4137
31724513	1167	1172	VS-AD	Disease	MESH:D000377
31724513	1173	1181	patients	Species	9606
31724513	1199	1202	tau	Gene	4137
31724513	1283	1288	VS-AD	Disease	MESH:D000377
31724513	1289	1297	patients	Species	9606
31724513	1454	1457	tau	Gene	4137
31724513	1474	1479	VS-AD	Disease	MESH:D000377
31724513	1480	1488	patients	Species	9606
31724513	1509	1533	visuospatial dysfunction	Disease	MESH:D000377
31724513	1537	1539	AD	Disease	MESH:D000544
31724513	Association	MESH:D000544	4137
31724513	Association	MESH:D019636	4137
31724513	Association	MESH:D000377	4137
31724513	Association	MESH:D003072	4137

